InvestorsHub Logo
Followers 47
Posts 696
Boards Moderated 0
Alias Born 05/12/2017

Re: ahp123 post# 492993

Thursday, 07/07/2022 9:50:15 AM

Thursday, July 07, 2022 9:50:15 AM

Post# of 688866
Flexibility, is my guess. As with many things NWBO, 100% NOT my area of expertise. NWBO at this stage needs to concentrate on their core competencies. Regulatory approval of their DC Vax products, expansion of indications they can be used for, combination trials, and the like.

Outsource manufacturing to a friendly, who can ramp up production and sell some services until the production is needed. Buy them out later if it makes more sense. The sort of thing that happened with Flaskworks.

Plus, it makes it harder to acquire NWBO in a hostile move as suddenly they have no production capacity anymore and their value plummets. All my guesses.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News